To assess how a patient with pulmonary arterial hypertension (PAH) is faring on therapy, look at the right heart, said Anjali ...

A new study published in The New England Journal of Medicine showed that for high-risk patients with pulmonary arterial ...

Yuan Lu, ScD, discusses a novel classification system she and colleagues developed to improve clinician adherence to hypertension treatment guidelines. Guidelines for severe hypertension management ...

Venous hypertension is a common medical condition, especially in older adults, when the blood pressure in your veins is higher than it should be. When healthcare providers use this term, they usually ...

Treatments approved for PAH may reduce by half the risk of serious complications or death in patients with repaired ...

A recent publication in the International Journal of Cardiology, Pulmonary ... hypertension,” commented Dr. Jenkins. “While our findings suggest a substantial role for PADN in treatment ...

A recent publication in the International Journal of Cardiology, "Pulmonary ... hypertension," commented Dr. Jenkins. "While our findings suggest a substantial role for PADN in treatment protocols ...

The new drug sotatercept stops the remodelling of the pulmonary vessels and even helps patients with advanced pulmonary arterial hypertension (PAH) who have not yet been treated. Pulmonary ...

Based on guidelines, PCWP is required to differentiate ... “estimating PCWP would facilitate earlier diagnosis and appropriate treatment of various conditions, including heart failure and [pulmonary ...

Sotatercept, a novel drug administered via subcutaneous injection, has shown significant efficacy in treating advanced pulmonary arterial hypertension (PAH), a condition previously deemed untreatable.